Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1-2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study

• Main Authors: Xiangyu WANG (Author), Yinqi GAO (Author), Xue YANG (Author), Xiangyi KONG (Author), Zixing WANG (Author), Yi FANG (Author), Jing WANG (Author)
• Format: Book
• Published: Tehran University of Medical Sciences, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Omitting axillary lymph node dissection (ALND) is recommended for early-stage breast cancer patients with 1-2 sentinel lymph nodes (SLNs) macro-metastases and breast-conserving therapy. However, it is not safe for part of patients, so it is significant to find risk factors and develop a...